| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/11/2007 | EP1771440A1 Generic probes for the detection of phosphorylated sequences |
| 04/11/2007 | EP1771438A1 1-3 substituted cycloamino derivatives and their use as histamine-3 receptor antagonists |
| 04/11/2007 | EP1771436A1 Kynurenic acid amide derivatives as nr2b receptor antagonists |
| 04/11/2007 | EP1771435A2 Modulators of central nervous system neurotransmitters |
| 04/11/2007 | EP1771432A2 Non-imidazole heterocyclic compounds as histamine h3 receptor modulators |
| 04/11/2007 | EP1771429A1 New benzoyl urea derivatives |
| 04/11/2007 | EP1771428A1 Guanidine derivatives and therapeutic uses thereof |
| 04/11/2007 | EP1771427A1 Prostaglandin analogs |
| 04/11/2007 | EP1771426A1 Diphenylamine-substituted salicylthiazole derivatives and related compounds as phosphotyrosine phosphatase 1b (ptp1b) inhibitors for using as blood-sugar decreasing active ingredients for treating diabetes |
| 04/11/2007 | EP1771425A1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
| 04/11/2007 | EP1771424A1 Novel 2,4-diaminothiazol-5-one derivatives |
| 04/11/2007 | EP1771422A1 Quinazolinone derivatives as parp inhibitors |
| 04/11/2007 | EP1771421A1 N-hydroxyamide derivatives and use thereof |
| 04/11/2007 | EP1771420A1 Novel 2,6-diaminopyridine-3-one derivatives |
| 04/11/2007 | EP1771418A2 Large conductance calcium-activated k channel opener |
| 04/11/2007 | EP1771417A1 Substituted 3-phenylpiperidine derivatives |
| 04/11/2007 | EP1771416A1 A novel polymorph of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine hydrochloride (donepezil hydrochloride) and a process for producing thereof |
| 04/11/2007 | EP1771415A1 2- (1h-indolylsulfanyl) -aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinence |
| 04/11/2007 | EP1771414A1 Amorphous tegaserod maleate |
| 04/11/2007 | EP1771413A2 Indole, benzofuran and benzothiphene derivatives as selective androgen receptor modulators (sarms) |
| 04/11/2007 | EP1771207A2 Methods for treating cancer using agents that inhibit wnt16 signaling |
| 04/11/2007 | EP1771203A2 Inhibition of nf-kb |
| 04/11/2007 | EP1771191A2 Preparation for use of aspartate and vitamin b12 or biotin for regulating ketone bodies |
| 04/11/2007 | EP1771188A2 Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia |
| 04/11/2007 | EP1771184A2 Calcium phosphate cements and methods for using the same |
| 04/11/2007 | EP1771183A2 Antimicrobial copolymers and uses thereof |
| 04/11/2007 | EP1771182A1 Anti-parasitic uses of borinic acid complexes |
| 04/11/2007 | EP1771181A2 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 04/11/2007 | EP1771180A1 Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase |
| 04/11/2007 | EP1771179A2 COMPOSITIONS COMPRISING 5-ALPHA REDUCTASE INHIBITORS, AND SERMs AND METHODS OF USE THEREOF |
| 04/11/2007 | EP1771178A1 Use of k-252a and kinase inhibitors for the prevention or treatment of hmgb1-associated pathologies |
| 04/11/2007 | EP1771177A2 Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |
| 04/11/2007 | EP1771176A2 Methods and compositions |
| 04/11/2007 | EP1771175A1 Phthalazine derivatives as parp inhibitors |
| 04/11/2007 | EP1771174A1 Method for treating abnormal cell growth |
| 04/11/2007 | EP1771173A1 Treatment of burns |
| 04/11/2007 | EP1771172A2 Treatment of tumours |
| 04/11/2007 | EP1771171A1 Use of alk 5 inhibitors to modulate or inhibit myostatin activity leading to increased lean tissue accretion in animals |
| 04/11/2007 | EP1771170A2 Ophthalmic compositions for treating ocular hypertension |
| 04/11/2007 | EP1771169A1 Methods for treating hepatitis c |
| 04/11/2007 | EP1771168A1 Compositions capable of inhibiting reactive oxygen and carbonyl species |
| 04/11/2007 | EP1771167A2 Histone deacetylase inhibitors |
| 04/11/2007 | EP1771166A2 Rxr antagonists in the treatment of inflammatory diseases |
| 04/11/2007 | EP1771165A1 Hydroalcoholic depigmentation gel comprising mequinol and adapalene |
| 04/11/2007 | EP1771164A1 Multitherapy against cancer |
| 04/11/2007 | EP1771163A1 Rxr antagonist treatment against multiple sclerosis |
| 04/11/2007 | EP1771162A2 Capsaicin inhibitors for treating obesity and related disorders |
| 04/11/2007 | EP1771161A1 Taste masking formulation comprising the drug in a dissolution-retarded form and/or cyclodextrin in a dissolution-enhanced form |
| 04/11/2007 | EP1771157A1 Multiparticle pharmaceutical dosage form for low-soluble active substances and method for producing said pharmaceutical dosage form |
| 04/11/2007 | EP1771156A1 Sterol enriched mixed lamellarity amphotericin intercalating liposomes in saline and the process for their preparation |
| 04/11/2007 | EP1771155A2 Method and composition for treating rhinitis |
| 04/11/2007 | EP1771154A1 Galenic applications of self-emulsifying mixtures of lipidic excipients |
| 04/11/2007 | EP1720538A4 Method for inducing cell death with carbonyl scavengers |
| 04/11/2007 | EP1696930B1 Tricyclic 1-((3-indol-3-yl)carbonyl)piperazine derivatives as cannabinoid cb1 receptor agonists |
| 04/11/2007 | EP1689385B1 Neuroactive substance and uses of one such substance |
| 04/11/2007 | EP1678164B1 Substituted pyrazinone compounds for the treatment of inflammation |
| 04/11/2007 | EP1641756B1 4-arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor |
| 04/11/2007 | EP1633325B1 Oil emulsion for postnatal hormone substitution |
| 04/11/2007 | EP1618117A4 Tumor selective and biodegradable polyphosphazene-platinum(ii) conjugate antitumor agent, and preparation method thereof |
| 04/11/2007 | EP1589834B1 Enteral composition for the prevention and/or treatment of sepsis |
| 04/11/2007 | EP1578422B1 A physically and chemically stable nicotine and micorcrystalline cellulose containing particulate material |
| 04/11/2007 | EP1567496B1 Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders |
| 04/11/2007 | EP1567163B1 Method of treating nausea, vomiting, retching or any combination thereof |
| 04/11/2007 | EP1555897B1 Ergogenic multivitamin-mineral energy supplement for the prevention of muscle fatigue |
| 04/11/2007 | EP1511759A4 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof. |
| 04/11/2007 | EP1499595B1 Amonafide salts |
| 04/11/2007 | EP1490093A4 Methods and compositions for the treatment of ischemia |
| 04/11/2007 | EP1480972B1 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders |
| 04/11/2007 | EP1458689B1 Aryloxyphenyl and arylsulfanylphenyl derivatives |
| 04/11/2007 | EP1439164B1 Novel phenylethanolamine compounds having beta2-acceptor excitatory function and their preparation method |
| 04/11/2007 | EP1414458B1 Oral administration of 6-hydroxy-oxymorphone for use as an analgesic |
| 04/11/2007 | EP1399444B1 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents |
| 04/11/2007 | EP1392641B1 Substituted cyclohexane-1,4-diamine derivatives |
| 04/11/2007 | EP1361854B1 Topical solution comprising a isoflavone aglycone |
| 04/11/2007 | EP1353952B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 04/11/2007 | EP1351938B1 Phenyl derivatives |
| 04/11/2007 | EP1342462B1 O/w emulsion composition and method of preparing the same |
| 04/11/2007 | EP1341767B1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 04/11/2007 | EP1313725B1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors |
| 04/11/2007 | EP1313471B1 Benzylidene thiazolidinediones and their use as antimycotic agents |
| 04/11/2007 | EP1300143B1 Patch containing 4-biphenylacetic acid |
| 04/11/2007 | EP1280416B1 Pet food composition for reducing inflammatory response in cats |
| 04/11/2007 | EP1272177B1 Method and formulation for treating resistance to antihypertensives and related conditions |
| 04/11/2007 | EP1267850B1 Use of insulin sensitivity increasing substances for the treatment of alopecia |
| 04/11/2007 | EP1239884B1 Methods for preparing pharmaceutical formulations |
| 04/11/2007 | EP1221861B1 Fat or oil composition |
| 04/11/2007 | EP1207868B1 Pharmaceutical tramadol salts |
| 04/11/2007 | EP1202725B1 Method of treating symptoms of hormonal variation, including hot flashes |
| 04/11/2007 | EP1147093B1 Substituted bicyclic derivatives useful as anticancer agents |
| 04/11/2007 | EP1123094B1 Therapeutic compositions (ii) |
| 04/11/2007 | EP1084107B1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
| 04/11/2007 | EP1073623B1 Substituted amino acids as erythropoietin mimetics |
| 04/11/2007 | EP1054894B1 Breast cancer resistance protein (bcrp) and the dna which encodes it |
| 04/11/2007 | EP1047420B1 Modulation of hair growth |
| 04/11/2007 | EP1019044B1 Composition and methods for treating alzheimer's disease and other amyloidoses |
| 04/11/2007 | EP1015439B1 Prenyl transferase inhibitors |
| 04/11/2007 | EP0980441B1 Methods for measuring cellular proliferation and destruction rates in vitro and in vivo |
| 04/11/2007 | EP0950656B1 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 04/11/2007 | EP0897726B1 Antipruritic agent |
| 04/11/2007 | EP0787122B1 Calcium receptor-active compounds |